RE:RE:RE:Unbelievable to me that StadaYou and every shareholder (me included) has and should be pissed right off with how LABS has performed over the past few years. Going from $7 to $0.26 is no small achievement.....and it takes efforts to be that bad.....which is infuriating.
And I agree, the partnerships they have spent years signing need to start bearing fruit. I think they thought as they were signing them that the pot sector was still in the 25% up for every NR phase....it isn't and will never be again, so none of them matter.....Stada notwithstanding.
I would disagree that they need to focus on Canada and that it's been opportunity lost there. Canada may be legal, but the roll out has been a mess and the number of players plenty, so really what niche is LABS to carve out there? I think the pharma angle is a good one and was a good pivot before others saw the potential, but the jury is out on whether the business or us shareholders can survive until that plan pays off. I'm not sure myself and I say that as a guy who has sunk way too much into this company. Just being another CPG pusher ain't going to win the day.....so go the medicinal route, smart.....
I think the Germany and Oz angles will pay off.....it's just time. I also think we're at the bottom....I mean shyte, can't expect this to go much lower can you? lol.
Like I said....I think they have the biz plan right....it's just whether we get diluted or RS or both before we long timers see a gain.....I got a fair bit to go to break even.....
Oceanis wrote: pharmacuetical companies have a vested interest in making sure cannabis doesn't become mainstream within medicine. There's a fox in the henhouse imo. In any case LABS doesnt need stada, so this new CEO better have a plan b. Or explain their buisness plan better, because all these partnerships with all these companies to date are fuk all to the shareholders.
They're so worried about being a "Global" cannabis company that they forgot to take care of their own backyard first. Last I heard cannnabis has been fully legalized in CANADA. LABS has shown zero ability to adapt to the changing cannabis landscape in Canada. Are we to wait for a decade for the rest of the world to legalize for share value to accumulate or, are we going to adapt and make monies for the shareholders, NOW.
They need ACTION. 26c.